Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice Regarding Settlement of Lawsuit
Sawai Pharmaceutical and Nichi-Iko Agree on Cooperation for Item Integration of Generic Drugs, etc.
SAWAI GROUP, Apr-Jun (1Q) Net Income Decreases by 68%
Notice Regarding the Expansion of Production Capacity at Trust Pharmatech's Seima Plants -Group to Manufacture 25 billionTablets by Fiscal Year 2030-
Consolidated Financial Results for the three months Ended June 30, 2025 (Under IFRS)
Corporate Governance Report (Revised Version)
Notice Regarding the Completion of Payment for New Shares as Restricted Share Compensation
Sawai Completes the Acquisition of Shares of FrontAct Co., Ltd. to Make It a Subsidiary
Corporate Governance Report
ARTICLES OF INCORPORATION
Notice Regarding the Issuance of New Shares as Restricted Share Compensation
Notice Regarding the Filing of a Final Appeal and the Petition for Acceptance of the Final Appeal
(Corrections Corrections of Numerical Data)Revision of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025
Notice Regarding Recording of Other Expenses (Provision for Loss on Litigation)
[Delayed]Notice Regarding Court Ruling Lawsuit Filed Against the Company’s Consolidated Subsidiary
Notice Regarding Revision of Corporate Officer Remuneration
Notice of Partial Amendment to the Articles of Incorporation
Notice Regarding Receipt of Dividend from Consolidated Subsidiary
Notice Regarding Officer Changes Following Transition to a Company with Audit and Supervisory Committee
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (Under IFRS)